Overview
I am a pediatric hematologist/oncologist who is passionate about improving the lives of children with cancer and blood disorders, regardless of where they live. During my fellowship training, I took time to complete a Master's in Global Health through the Duke Graduate School, and gained significant experience working abroad in Tanzania. As a member of faculty, I have continued that research in Tanzania, focusing on using implementation science methodology to adapt chemotherapy regimens for their safe use in low resource settings.
When in the US, I focus on clinical research in a variety of different fields as well as quality improvement. Current focuses include pediatric cancer survivorship and clinical outcomes such as fever in patients with severe neutropenia.
When in the US, I focus on clinical research in a variety of different fields as well as quality improvement. Current focuses include pediatric cancer survivorship and clinical outcomes such as fever in patients with severe neutropenia.
Current Appointments & Affiliations
Assistant Professor of Pediatrics
·
2025 - Present
Pediatrics, Hematology-Oncology,
Pediatrics
Member of the Duke Cancer Institute
·
2025 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Implementation Science Methodology for the Successful Introduction of High-Dose Methotrexate for the Treatment of Pediatric Mature B-Cell Non-Hodgkin Lymphoma in a Resource-Limited Setting.
Journal Article Pediatr Blood Cancer · March 2026 BACKGROUND: Despite the excellent outcomes achieved for pediatric mature B-cell non-Hodgkin lymphoma (MB-NHL) in high-income countries, outcomes remain very poor in low- and middle-income countries. High-dose methotrexate (HD-MTX), which is highly efficaci ... Full text Link to item CiteProspective Psychometric Validation of the Swahili Translated and Adapted Pediatric Patient Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE).
Journal Article Meas Eval Cancer Care · December 2025 BACKGROUND: High quality clinical research is necessary in order to address the significant disparities in pediatric cancer outcomes seen in low- and middle-income countries (LMICs). Patient reported outcomes are now recognized as a critical part of many c ... Full text Link to item CiteAbstract 18: Use of Patient Reported Outcomes to Assess Treatment Associated Toxicities for Pediatric Burkitt Lymphoma Patients in Tanzania
Conference Cancer Epidemiology, Biomarkers & Prevention · December 1, 2025 AbstractPurpose:Despite their increasing use in clinical practice and research in high resource settings, the use of patient re ... Full text CiteEducation
Tufts University, School of Medicine ·
2018
M.D.